Stefan Kluge, MD

University Medical Center Hamburg-Eppendorf, Germany

Disclosure(s): Astrazeneca: Lecture fees; Biotest: Lecture fees; Cytosorbents: Grant/Research Support, Lecture fees; Daiichi Sankyo: Grant/Research Support, Lecture fees; Fresenius Medical Care: Advisor/Consultant, Lecture fees; Gilead: Advisor/Consultant, Lecture fees; Mitsubishi Tanabe Pharma: Lecture fees; MSD: Advisor/Consultant, Lecture fees; Pfizer: Advisor/Consultant, Lecture fees; Phillips: Lecture fees; Zoll: Lecture fees

Poster(s):

• 673 - Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA): Results from a multi-national, multicenter observational study
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET